scispace - formally typeset
F

Florian Fuchs

Researcher at Novartis

Publications -  41
Citations -  2087

Florian Fuchs is an academic researcher from Novartis. The author has contributed to research in topics: Mitochondrion & Computer science. The author has an hindex of 13, co-authored 34 publications receiving 1787 citations. Previous affiliations of Florian Fuchs include German Cancer Research Center & Ludwig Maximilian University of Munich.

Papers
More filters
Journal ArticleDOI

EBImage—an R package for image processing with applications to cellular phenotypes

TL;DR: EBImage provides general purpose functionality for reading, writing, processing and analysis of images and in the context of microscopy-based cellular assays, EBImage offers tools to segment cells and extract quantitative cellular descriptors.
Journal ArticleDOI

Genetic basis of mitochondrial function and morphology in Saccharomyces cerevisiae.

TL;DR: A systematic screen of a deletion mutant library covering the nonessential genes of Saccharomyces cerevisiae revealed unprecedented mitochondrial phenotypes that have never been observed by conventional screens, providing a comprehensive picture of the cellular processes and molecular components required for mitochondrial function and structure in a simple eukaryotic cell.
Journal ArticleDOI

Clustering phenotype populations by genome-wide RNAi and multiparametric imaging.

TL;DR: Examination of several candidates including the largely uncharacterized gene DONSON, which shared phenotype similarity with known factors of DNA damage response (DDR), supports that DONSON is a novel centrosomal protein required for DDR signalling and genomic integrity.
Journal ArticleDOI

Proteins Required for Centrosome Clustering in Cancer Cells

TL;DR: It is shown that spindle tension is required to cluster multiple centrosomes into a bipolar spindle array in tumor cells with supernumerary centrosome, and that interfering with any of the proteins found in the screen could, in principle, eliminate this tension and prevent bundling, leading to tumor cell death.
Journal ArticleDOI

Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development

TL;DR: It is found that the level of qualification of MPS-based assays for a given context of use and communication gaps between stakeholders are the major challenges slowing industrial adoption by end users, which in turn is causing a regulatory acceptance dilemma.